Abstract
Patients with peripheral artery disease (PAD) are at increased risk for subsequent ischemic events. We used data from the FRENA Registry to find predictors of subsequent myocardial infarction (MI), ischemic stroke, and limb amputation in stable outpatients with PAD. As of January 2012, 1,270 patients with PAD were recruited, of whom 1,042 (82 %) had Fontaine stage II; 113 (8.9 %) stage III; and 115 (9.1 %) stage IV. Over a mean follow-up of 14 months, 35 patients developed MI, 25 had stroke, 39 underwent limb amputation, and 91 died. Among patients with Fontaine stage II, the incidence of MI (2.09 events per 100 patient-years; 95 % CI 1.43–2.97) or stroke (0.93; 95 % CI 0.52–1.56) was similar to that of limb amputation (3.22; 95 % CI 2.37–4.29). On multivariate analysis, patients with diabetes [hazard ratio (HR) 2.09; 95 % CI 1.05–4.18], prior coronary disease (HR 5.35; 95 % CI 2.24–12.8), or atrial fibrillation (HR 3.11; 95 % CI 1.52–6.37) were at increased risk for MI; female (HR 2.94; 95 % CI 1.32–6.67), those with prior stroke (HR 5.21; 95 % CI 1.22–22.2) or atrial fibrillation (HR 3.37; 95 % CI 1.45–7.85) at increased risk for stroke; and female (HR 2.38; 95 % CI 1.23–4.55), those with diabetes (HR 3.50; 95 % CI 1.58–7.73) or advanced stages of PAD were at increased risk for limb amputation. Prior coronary artery disease, diabetes and atrial fibrillation predicted subsequent MI; female gender, prior stroke and atrial fibrillation predicted stroke; and female gender, diabetes, and advanced stages of PAD predicted limb amputation.
Similar content being viewed by others
References
Criqui MH, Langer RD, Fronck A, Feigelson HS, Klauber MR, McCann TJ, Bowner D (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326:381–386
Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, Powe NR, Siscovick D (1999) Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 19:538–545
Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S, Pittrow D, von Stritzky B, Tepohl G, Trampisch HJ (2004) High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 172:95–105
Cimminiello C, Kownator S, Wautrecht JC, Carvounis CP, Kranendonk SE, Kindler B, Mangrella M, Borghi C, PANDORA Study Investigators (2011) The PANDORA study: peripheral arterial disease in patients with non-high cardiovascular risk. Intern Emerg Med 6:509–519
Busti C, Falcinelli E, Momi S, Gresele P (2010) Matrix metalloproteinases and peripheral arterial disease. Intern Emerg Med 5:13–25
Third report of the National Cholesterol Education Program (NCEP) (2002) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143–3421
Dormandy JA, Rutherford B (2000) Management of peripheral arterial disease (PAD) TASC Working Group. Trans Atlantic Inter-Society Consensus (TASC). J Vasc Surg 31:S1–S96
Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Smith SC Jr, Stone NJ (2004) Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110:227–239
Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA, AHA/ACC (2006) National Heart, Lung, and Blood Institute. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113:2363–2372
Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Röther J (2006) REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295:180–189
Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, Creager MA, Easton JD, Gavin JR 3rd, Greenland P, Hankey G, Hanrath P, Hirsch AT, Meyer J, Smith SC, Sullivan F, Weber MA (2003) Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 163:884–892
Cacoub PP, Abola MT, Baumgartner I, Bhatt DL, Creager MA, Liau CS, Goto S, Röther J, Steg PG, REACH Registry Investigators (2009) Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction in Atherothrombosis for Continued Heatl (REACH) Registry. Atherosclerosis 204:e86–e92
Saw J, Bhatt DL, Moliterno DJ, Brener SJ, Steinhubl SR, Lincoff AM, Thenc JE, Harrington RA, Simoons M, Hu T, Sheikh MA, Kereiakes DJ, Topol EJ (2006) The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomised percutaneous coronary intervention trials. J Am Coll Cardiol 48:1567–1572
Rehring TF, Stolcpart RS, Hollis HW Jr (2008) Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons. J Vasc Surg 47:1108–1115
Barba R, Bisbe J, Pedrajas JN, Toril J, Monte R, Muñoz-Torrero JF, Monreal M, the FRENA Investigators (2009) Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA Registry. Eur J Cardiovasc Prev Rehabil 17:456–463
Suriñach JM, Alvarez LR, Coll R, Carmona JA, Sanclemente C, Aguilar E, Monreal M (2009) Differences in cardiovascular mortality in smokers, past-smokers and non-smokers. Findings from the FRENA Registry. Eur J Intern Med 20:522–526
Camafort M, Alvarez-Rodríguez LR, Muñoz-Torrero JF, Sahuquillo JC, López-Jiménez L, Coll R, Monreal M (2011) Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA Registry. Diabet Med 28:73–80
García-Díaz AM, Marchena PJ, Toril J, Arnedo G, Sánchez Muñoz-Torrero JF, Yeste M, Aguilar E, Monreal M (2011) Alcohol consumption and outcome in stable outpatients with peripheral artery disease. J Vasc Surg 54:1081–1087
Pasqualini L, Schillaci G, Vaudo G, Innocente S, Ciuffetti G, Mannarino E (2001) Predictors of overall and cardiovascular mortality in peripheral arterial disease. Am J Cardiol 88:1057–1060
Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41
Martin DO, Austin H (1996) Exact estimates for a rate ratio. Epidemiology 7:29–33
Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B (2006) American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Trans-Atlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113:e463–654
The ICAI Group (Gruppo di studio dell’ischemia cronica critica degli arti inferiori) (1997) Long-term mortality and its predictors in patients with critical leg ischemia: Eur J Vasc Endovasc Surg 14:91–95
Acknowledgments
We express our gratitude to S & H Medical Science Service for their quality control, logistic and administrative support. We thank Salvador Ortíz, Prof. Universidad Autónoma de Madrid and Statistical Advisor S & H Medical Science Service for the statistical analysis of the data presented in this paper.
Conflict of interest
None.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
A full list of FRENA investigators is given in the Appendix.
Appendix: Members of the FRENA Group
Appendix: Members of the FRENA Group
Aguilar E, Álvarez LR, Arnedo G, Coll R, García-Díaz A, Fuentes E, Monreal M, Mujal A, Pascual MT, Sahuquillo JC, Sánchez Muñoz-Torrero JF, Sanclemente C, Suárez C, Suriñach JM, Toril J, Yeste M.
Rights and permissions
About this article
Cite this article
Sanclemente, C., Yeste, M., Suarez, C. et al. Predictors of outcome in stable outpatients with peripheral artery disease. Intern Emerg Med 9, 69–77 (2014). https://doi.org/10.1007/s11739-012-0854-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-012-0854-1